Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-005015
Filing Date
2017-03-21
Accepted
2017-03-21 17:07:25
Documents
1
Period of Report
2017-03-17

Document Format Files

Seq Description Document Type Size
1 GILBERTSON FORM 4 - 2017-03-17 rdgdoc.html 4  
1 GILBERTSON FORM 4 - 2017-03-17 rdgdoc.xml 4 4974
  Complete submission text file 0001437749-17-005015.txt   6483
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Issuer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 130 LAKE ST. WEST WAYZATA MN 55391
Business Address
GILBERTSON RYAN RANDALL (Reporting) CIK: 0001394821 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55242 | Film No.: 17704836